SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-016676
Filing Date
2022-06-14
Accepted
2022-06-14 09:45:09
Documents
1
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1572
  Complete submission text file 0001493152-22-016676.txt   3217
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1524 CLOVERFIELD BOULEVARD SUITE E SANTA MONICA CA 90404
Business Address
URBAN ALAN LOUIS (Reporting) CIK: 0001534376 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40023 | Film No.: 221013585